Proteomics and Cr(VI) Exposure: Exploring New Biomarkers in Humans

Qingshan Qu,Yixin Lin,Xiaomei Li,Roy E. Shore,Feiyun An,Guang Jia,Lanzheng Liu,Yu Hu,Beverly S. Cohen,Max Costa
IF: 11.2
2005-01-01
Cancer Research
Abstract:2207 Hexavalent chromium [Cr(VI)] is present as one of the major contaminants at numerous Superfund toxic waste dump sites and is a well established human carcinogen. In the present study, 10 exposed and 10 unexposed male subjects were recruited from a Chinese occupational population for proteomic analyses using SELDI ProteinChip® technology to determine if there are proteins in plasma that can be used to distinguish between exposed and unexposed subjects. In the meantime, a number of biomarkers for Cr(VI) exposure and biological effects, including Cr levels in red blood cells (RBC), DNA protein cross link (DPC), comet assay in lymphocytes, and urinary 8-hydroxydeoxyguanosine (8-OHdG), were also determined. The mean personal exposure levels of Cr(VI) were 0.09 μg/m3 and 265.9 μg/m3 in unexposed and exposed subjects, respectively. DPC was found significantly higher in exposed than in unexposed subjects (p
What problem does this paper attempt to address?